JPS54962B2 - - Google Patents

Info

Publication number
JPS54962B2
JPS54962B2 JP2522576A JP2522576A JPS54962B2 JP S54962 B2 JPS54962 B2 JP S54962B2 JP 2522576 A JP2522576 A JP 2522576A JP 2522576 A JP2522576 A JP 2522576A JP S54962 B2 JPS54962 B2 JP S54962B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2522576A
Other versions
JPS52108027A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2522576A priority Critical patent/JPS52108027A/ja
Priority to GB8910/77A priority patent/GB1573965A/en
Priority to FR7706762A priority patent/FR2343475A1/fr
Priority to CA273,441A priority patent/CA1093971A/en
Priority to NLAANVRAGE7702535,A priority patent/NL172917C/xx
Priority to DE2710327A priority patent/DE2710327C3/de
Priority to BE175645A priority patent/BE852283A/xx
Priority to AU23073/77A priority patent/AU499475B2/en
Publication of JPS52108027A publication Critical patent/JPS52108027A/ja
Publication of JPS54962B2 publication Critical patent/JPS54962B2/ja
Priority to US07/265,415 priority patent/US4983636A/en
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2522576A 1976-03-09 1976-03-09 Anticarcinogen Granted JPS52108027A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen
GB8910/77A GB1573965A (en) 1976-03-09 1977-03-02 Carcinostatic compositions
FR7706762A FR2343475A1 (fr) 1976-03-09 1977-03-08 Composition carcinostatique et procede de traitement d'une maladie maligne
CA273,441A CA1093971A (en) 1976-03-09 1977-03-08 Carcinostatic composition and method of treating a malignant condition
DE2710327A DE2710327C3 (de) 1976-03-09 1977-03-09 Verwendung von Benzaldehyd
NLAANVRAGE7702535,A NL172917C (nl) 1976-03-09 1977-03-09 Werkwijze voor het bereiden van een geneesmiddel tegen kanker.
BE175645A BE852283A (fr) 1976-03-09 1977-03-09 Compositions carcinostatiques et leur utilisation
AU23073/77A AU499475B2 (en) 1976-03-09 1977-03-09 Anti-malignant tumor composition
US07/265,415 US4983636A (en) 1976-03-09 1988-10-31 Composition and method of treating selected malignant conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Publications (2)

Publication Number Publication Date
JPS52108027A JPS52108027A (en) 1977-09-10
JPS54962B2 true JPS54962B2 (ja) 1979-01-18

Family

ID=12160014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2522576A Granted JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Country Status (9)

Country Link
US (1) US4983636A (ja)
JP (1) JPS52108027A (ja)
AU (1) AU499475B2 (ja)
BE (1) BE852283A (ja)
CA (1) CA1093971A (ja)
DE (1) DE2710327C3 (ja)
FR (1) FR2343475A1 (ja)
GB (1) GB1573965A (ja)
NL (1) NL172917C (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017043616A (ja) * 2015-08-27 2017-03-02 学校法人慶應義塾 １４−３−３タンパク質活性調節剤
JP2020061958A (ja) * 2018-10-16 2020-04-23 株式会社ワールドナッツ アーモンドペースト組成物
JP2022171109A (ja) * 2021-04-30 2022-11-11 潤 齋藤 Ａｘｌ阻害剤

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446001U (ja) * 1977-09-07 1979-03-30
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
JPS6112623A (ja) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd エンケフアリナ−ゼ阻害剤
JPS6256423A (ja) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
JPH0269540A (ja) * 1988-09-05 1990-03-08 Chisso Corp 結晶性ポリオレフイン組成物
US5330744A (en) * 1988-11-14 1994-07-19 Sloan-Kettering Institute For Cancer Research Method for increasing sensitivity to chemically induced terminal differentiation
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5789189A (en) * 1993-09-24 1998-08-04 The Regents Of The University Of California Inhibition of cyst formation by cytoskeletal specific drugs
GB2298791B (en) * 1995-03-13 1999-05-05 Stepan Co Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria
EA200601252A1 (ru) * 1999-09-08 2006-10-27 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US7195788B2 (en) * 2001-03-30 2007-03-27 Premier Botanicals, Ltd. Pesticidal compositions from prunus
AU2004228011A1 (en) * 2003-04-01 2004-10-21 Memorial Sloan-Kettering Cancer Center Hydroxamic acid compounds and methods of use thereof
JP7054085B2 (ja) * 2016-06-30 2022-04-13 Ｓｈｉｏｄａライフサイエンス株式会社 バラ科サクラ属に属する植物の葉の抽出液を含有する抗腫瘍剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOCHEMICAL JOURNAL=1938 *
TOXICOLOGY=1975 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017043616A (ja) * 2015-08-27 2017-03-02 学校法人慶應義塾 １４−３−３タンパク質活性調節剤
JP2020061958A (ja) * 2018-10-16 2020-04-23 株式会社ワールドナッツ アーモンドペースト組成物
JP2022171109A (ja) * 2021-04-30 2022-11-11 潤 齋藤 Ａｘｌ阻害剤

Also Published As

Publication number Publication date
AU499475B2 (en) 1979-04-26
NL172917B (nl) 1983-06-16
AU2307377A (en) 1978-09-14
CA1093971A (en) 1981-01-20
DE2710327C3 (de) 1981-02-12
BE852283A (fr) 1977-09-09
JPS52108027A (en) 1977-09-10
NL7702535A (nl) 1977-09-13
DE2710327B2 (de) 1980-04-17
FR2343475B1 (ja) 1980-04-25
GB1573965A (en) 1980-08-28
NL172917C (nl) 1983-11-16
FR2343475A1 (fr) 1977-10-07
US4983636A (en) 1991-01-08
DE2710327A1 (de) 1977-09-15

Similar Documents

Publication Publication Date Title
DK141212C (ja)
CH637799B (ja)
DK88977A (ja)
FI52131B (ja)
JPS5541780B2 (ja)
FI760280A (ja)
DE2632424C2 (ja)
DE2608011C3 (ja)
FI52644B (ja)
JPS5376318U (ja)
FI760169A (ja)
JPS5357467U (ja)
DE7610659U1 (ja)
CH606475A5 (ja)
DD123742A5 (ja)
CH597372A5 (ja)
CH597415A5 (ja)
CH597484A5 (ja)
CH597877A5 (ja)
CH598848A5 (ja)
CH603378A5 (ja)
CH604351A5 (ja)
CH604441A5 (ja)
CH604445A5 (ja)
CH597059A5 (ja)